AurumNews - The Aurum Institute

US Senate Representative Applauds Efforts to Support Key Populations in Tshwane

...
New Research Hub Launched to Study Health and Social Impact of Mining and Migration in Royal Bafokeng Nation

JOHANNESBURG, 27 November 2024. The BAMMISHO Node, or Bafokeng Health & Demographic Surveillance System (HDSS), has been officially launched as the latest South African Population Research Infrast...
World AIDS Day 2024: A Journey of Resilience, Hope, and Advocacy

Thandi Shabangu’s story is one of resilience, transformation, and unwavering commitment to helping others. A member of the Community Advisory Board at The Aurum Institute, Thandi has dedicated much ...
DRTB-HDT Annual Consortium Meeting

The DRTB-HDT Annual Consortium Meeting brought together global collaborators, reflecting on achievements and outlining strategies for the upcoming year. Hosted by The Aurum Institute, the event conclu...
New clinic hosts successful collaborative outreach programme

...
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Garrett N, Reddy T, Yende-Zuma N, Takalani A, Woeber K, Bodenstein A, Jonas P, Engelbrecht I, Jassat W, Moultrie H, Bradshaw D, Seocharan I, Odhiambo J, Khuto K, Richardson SI, Omondi MA, Nesamari R, ...
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M(TM) adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.

Shinde V, Lombard Koen A, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MSL, Moodley D, Hanley S, Fouche LF, Louw C, Tameris M, Singh N, Goga A, Dheda K, Grobbelaar C, Joseph N, Lombaa...
High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort.

Gati Mirembe B, Donnell D, Krows M, Zwane Z, Bukusi E, Panchia R, Louw C, Mwelase N, Selepe P, Senne M, Naidoo L, Chihana R, Kasaro M, Nuwagaba-Biribonwoha H, Kotze P, Gill K, MacDonald P, vanHeerden ...
. Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia

Goscé L, Tadesse AW, Foster N, van Kalmthout K, Rest JV, van der Wal J, Harker MJ, Madden N, Abdurhman T, Gadissa D, Bedru A, Dube TN, Alacapa J, Mganga A, Deyanova N, Charalambous S, Letta T, Jerene...
Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.

Nazziwa J, Freyhult E, Hong MG, Johansson E, Årman F, Hare J, Gounder K, Rezeli M, Mohanty T, Kjellström S, Kamali A, Karita E, Kilembe W, Price MA, Kaleebu P, Allen S, Hunter E, Ndung'u T, Gilmour ...
Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment.

Cumming BM, Addicott KW, Maruri F, Pillay V, Asmal R, Moodley S, Barreto-Durate B, Araújo-Pereira M, Mazibuko M, Mhlane Z, Mbatha N, Khan K, Makhari S, Karim F, Peetluk L, Pym AS, Moosa MYS, van der ...
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.

Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, Doblecki-Lewis S, Gallardo-...
Facilitators and barriers to uptake of digital adherence technologies in improving TB care in Ethiopia: A qualitative study

Shewamene Z, Belachew M, Shiferaw A, De Groot L, Sahlie M, Gadissa D, Abdurhman T, Bedru A, Leta T, Dube T, Deyanova N, Jerene D, Fielding K, Tadesse AW. Facilitators and barriers to uptake of digital...
WhatsApp Versus SMS for 2-Way, Text-Based Follow-Up After Voluntary Medical Male Circumcision in South Africa: Exploration of Messaging Platform Choice.

Fabens I, Makhele C, Igaba NK, Hlongwane S, Phohole M, Waweru E, Oni F, Khwepeya M, Sardini M, Moyo K, Tweya H, Wafula MB, Pienaar J, Ndebele F, Setswe G, Dong TQ, Feldacker C. WhatsApp Versus SMS fo...
. Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Naicker V, Laher F, Bekker LG, Seaton KE, Allen M, De Rosa S, Yates NL, Mkhize NN, Saunders K, Heptinstall J, Malahleha M, Mngadi K, Daniels B, Innes C, Yu C, Modise T, Bekker V, Grunenberg N, Furch B...
. Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Naicker V, Laher F, Bekker LG, Seaton KE, Allen M, De Rosa S, Yates NL, Mkhize NN, Saunders K, Heptinstall J, Malahleha M, Mngadi K, Daniels B, Innes C, Yu C, Modise T, Bekker V, Grunenberg N, Furch B...
Burden of tuberculosis in underserved populations in South Africa: A systematic review and meta-analysis.

Holtgrewe LML, Johnson A, Nyhan K, Boffa J, Shenoi SV, Karat AS, Davis JL, Charalambous S. Burden of tuberculosis in underserved populations in South Africa: A systematic review and meta-analysis. PLO...
Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol.

Myers H, Chongo B, Zifodya JS, Zacaria I, Machava E, Simango A, Amorim G, Mavume-Mangunyane E, Chiau R, Kampa KT, Madede T, Sidat M, Moon TD. Implementation of spirometry screening for post-tuberculo...
Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial

Bennett C, Hoosain Z, Koen A, Lalloo U, Louw C, Maluleke V, Patel F, Benade G, Venter EL, Galbiati S, Shinde V, Madhi SA. Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in ...
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.

Huang Y, Alam S, Andersen-Nissen E, Carpp LN, Dintwe OB, Flach BS, Grunenberg N, Laher F, De Rosa SC, Ferrari G, Innes C, Bekker LG, Kublin JG, McElrath MJ, Tomaras GD, Gray GE, Gilbert PB. Non-HIV V...

US Senate Representative Applauds Efforts to Support Key Populations in Tshwane

New Research Hub Launched to Study Health and Social Impact of Mining and Migration in Royal Bafokeng Nation

World AIDS Day 2024: A Journey of Resilience, Hope, and Advocacy

DRTB-HDT Annual Consortium Meeting

New clinic hosts successful collaborative outreach programme

Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M(TM) adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.

High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort.

. Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia

Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.

Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatment.

Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.

Facilitators and barriers to uptake of digital adherence technologies in improving TB care in Ethiopia: A qualitative study

WhatsApp Versus SMS for 2-Way, Text-Based Follow-Up After Voluntary Medical Male Circumcision in South Africa: Exploration of Messaging Platform Choice.

. Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

. Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial.

Burden of tuberculosis in underserved populations in South Africa: A systematic review and meta-analysis.

Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol.

Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living With and Without HIV-1 Infection: A Phase 2 Randomised Trial

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.

Popular Tags

Most Read

Recent Posts